Riskpilot← Back to searchSign inGet full accessDaiichi Sankyo Nordics ApS
APSActiveCVR 39371049Amagerfælledvej 106, 2.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201829 employees
Revenue 2025
DKK 69,5M
+21% vs 2024
EBITDA margin
20.3%
-9% vs 2024
Equity ratio
8.8%
Financial strength
Net profit 2025
DKK 9M
+7% vs 2024
| Revenue | DKK 69,5M | +21% |
| EBITDA | DKK 14,1M | -9% |
| Net profit | DKK 9M | +7% |
| Total assets | DKK 261,5M | +44% |
| Equity | DKK 23,1M | +64% |
| Employees | 29 | — |
Legal name
Daiichi Sankyo Nordics ApS
CVR number
39371049
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28. februar 2018
Share capital
DKK 100.000
Employees
29 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-03-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen eller af den samlede bestyrelse.
Company purpose
Selskabets formål er forskning og udvikling, handel, markedsføring og distribution, import og eksport, licenssøgning samt lignende aktiviteter inden for farmaceutiske, kemiske, biokemiske, medicinske og veterinærmedicinske, biologiske, hygieniske, kosmetiske og lignende produkter og apparater, herunder medicinske hjælpemidler.
Address
Amagerfælledvej 106, 2.
Phone
+4527219263
Email
charlotte.randlov@daiichi-sankyo.eu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 27.407 | 35.621 | 47.833 | 57.381 | 69.482 |
| Staff expenses | -25.370 | -34.898 | -40.512 | -41.889 | -55.391 |
| EBITDA | 1.500 | 723 | 7.321 | 15.493 | 14.077 |
| Depreciation & amort. | -344 | -430 | -423 | -319 | -671 |
| EBIT | 1.156 | 292 | 6.898 | 15.174 | 13.405 |
| Net financials | -41 | -342 | -4.173 | -3.465 | -1.302 |
| Profit before tax | 1.115 | -50 | 2.726 | 11.709 | 12.103 |
| Tax | 269 | -96 | 376 | 3.260 | 3.082 |
| Net profit | 846 | 46 | 2.350 | 8.449 | 9.021 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 19.755 | 48.945 | 106.680 | 181.342 | 261.484 |
| Equity | 3.337 | 3.383 | 5.733 | 14.056 | 23.077 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 16.418 | 45.562 | 100.946 | 167.286 | 238.407 |
| Total debt | 16.418 | 45.562 | 100.946 | 167.286 | 238.407 |
EBITDA margin
20.3%
This company
15.8%
Market median
+28% vs market
20212025
Equity ratio
8.8%
This company
38.2%
Market median
-77% vs market
20212025
Return on equity
39.1%
This company
18.4%
Market median
+113% vs market
20212025
Net profit margin
13.0%
This company
8.1%
Market median
+60% vs market
20212025
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20212025
Debt / equity
10.33×
This company
0.62×
Market median
-1566% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CT Management | Management | 2026 |
UF Founder | Founder | 2018 |
| Former (3) | ||
NT Management | Management | 2020 – 2020 |
PJ Chief Executive Officer | Chief Executive Officer | 2018 – 2020 |
ÅM Management | Management | 2020 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2023 | |
| Former (4) | ||
| Board of Directors | 2019 – 2022 | |
| Board of Directors | 2019 – 2023 | |
| Board of Directors | 2019 – 2019 | |
| Chairman | 2019 – 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Daiichi Sankyo Nordics ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nicola Torosantucci | Management | 0 companies |
| Patrik Josef Grandits | Chief Executive Officer | 0 companies |
| Åke Magnus Gisel | Management | 0 companies |
| Christophe Tiberghien | Management | 0 companies |
| Ulrik Fleischer-Michaelsen | Founder | 0 companies |
| Tim Ellmers | Board of Directors | 0 companies |
| Karin Margaretha Heisterberg | Board of Directors | 0 companies |
| Stefan Gerd Koch | Board of Directors | 0 companies |
| Stefan Gerd Koch | Board of Directors | 0 companies |
| Patrik Josef Mag. Grandits | Chairman | 0 companies |
| Jacob Wessel-Tolvig | Board of Directors | 0 companies |